InvestorsHub Logo
icon url

horselover45

01/27/14 7:02 PM

#158259 RE: EYEBUYSTOX #158256

It looks like the next presentation is only 10 minutes long.

IF I was a betting person I would lay my money down on that the oral is connected to Bruce's presentation.

Just an amateur's observation.
icon url

purpledawgs

01/27/14 7:02 PM

#158260 RE: EYEBUYSTOX #158256

Eyebuy:

Looks like it is the one after us. Look at this agenda (scroll to very end) and you will see a similar format. The oral abstract is above the title.

http://www.gtcbio.com/conference/protein-kinases-in-drug-discovery-agenda

However, look at the time for presentation. We get 25 minutes. The two presentations after us only get 10 minutes each.

IMO

Pd
icon url

microbe_man

01/27/14 7:10 PM

#158261 RE: EYEBUYSTOX #158256

It is for the next abstract. In meetings like this, some oral presentation slots are chosen from the outstanding abstracts that would normally be slated for posters. They pick some of the more interesting abstracts and then give them a shorter time for the presentation. However, I am very much looking forward to what Freimark says and sure hope it is better than the CTLA-4+ Bavi poster that was presented in Dec.
icon url

MazelMan

01/27/14 7:13 PM

#158262 RE: EYEBUYSTOX #158256

Eye. Did the short position indicate anything to you about the box ?

Thanks

Dave
icon url

Protector

01/28/14 8:37 AM

#158293 RE: EYEBUYSTOX #158256

EBS, it is not for PPHM's presentation.
PPHM has a standard 25 min slot.

The two last presentations are those [Oral Presentation from Exemplary Submitted Abstracts] and have only 10 minute slots.

Also remember that this event is in San Diego and that it is reasonable to assume that presentation time is in Pacific and therefore near end of Nasdaq AFTER HOURS. A dangerous situation for all kinds of manipulations to hit stops or to surprise short positions. And NO OPTION trading possible till next day's main session open - so no quick option hedging/protecting of the position if this takes of in either direction.


In the past PPHM has PRed presentations if they were important (e.g. Sept 7th one) and has just mentioned, and a couple of times not mentioned, neither listed on their event web-page, some activities.

I assume that is where we can see how important PPHM estimates the event to be. If they issue a reminder PR for the 30th JAN presentation then I assume they find it important (which may mean new information or new insights) and if not it could be they just see it as "spreading the word" on PS targeting.

Furthermore Bruce Freimark is one of their own.

Bruce Freimark
Director, Pre-Clinical Development
Peregrine Pharmaceuticals


PPHM is normally more PR-happy when Thrope, now Brekken, and other UTSW and now possibly also their new KOL's PPHM's Key Opinion Leaders in Advisory Board give presentations.

We'll see!